Meeting to be held in New York on September 30 hosted by Piper Sandler.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO:
- Korro Bio’s Promising RNA Editing Advances and Market Potential Highlighted by Buy Rating
- Korro Bio’s KRRO-110: Promising Safety, Efficacy, and Commercial Potential Drive Buy Rating
- Korro Bio price target lowered to $90 from $100 at H.C. Wainwright
- Korro Bio Advances RNA Editing Programs in Q2 2025
- Korro Bio reports Q2 EPS ($2.74), consensus ($2.59)